FDA Issues Final Guidance on Terminology for Veterinary Medicinal Products Adverse Event Reporting

The U.S. Food and Drug Administration issued a final guidance document today to help drug manufacturers submit accurate and consistent adverse event reports related to animal medicinal products, also known as animal drugs.

The final guidance, GFI 143: Pharmacovigilance of Veterinary Medicinal Products: Controlled List of Termsoutlines the terms that should be used when submitting an adverse event report to FDA. This guidance complements GFI 188, “Data Elements for Submission of Veterinary Adverse Event Reports to the Center for Veterinary Medicine,” which provides instructions for veterinary drug adverse event reporting. GFI 143 also includes steps to keep the lists of terms up to date.

Controlled lists of terms are important for assessing the safety and efficacy of veterinary medicinal products because they help ensure consistency and allow easier comparison between veterinary medicinal products and across product classes.

Trending Articles
Prep Site for Injection in Horse
So You Want to Be an Equine Veterinary Technician? 
Purebred stallion in bandages standing on pasturage. Multicolored exterior image
Disease Du Jour: Immune System’s Role in Equine Osteoarthritis 
Veterinarian with horses on ranch
Veterinary Wellness Briefs: Living With Chronic Pain 
Happy to help
AAEP Commission on Veterinary Sustainability: Improved Internships Will Help Retention 
Get the best from EquiManagement delivered straight to your inbox once a week! Topics include horse care, disease alerts, and vet practitioner updates.

"*" indicates required fields


Additional Offers

This field is for validation purposes and should be left unchanged.